Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Bio-Path Holdings, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $73.41M | $73.41M - $73.41M | $0.00 | $2.14 | 1 |
| Dec 2028 | $48.33M | $48.33M - $48.33M | $0.00 | $1.50 | 1 |
| Dec 2027 | $39.84M | $39.84M - $39.84M | $0.00 | -$1.37 | 1 |
| Dec 2026 | $40.05M | $40.05M - $40.05M | $0.00 | -$1.42 | 1 |
| Dec 2025 | $21.61M | $21.61M - $21.61M | $0.00 | -$1.59 | 1 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$3.17 | 0 |
| Dec 2020 | $81.44M | $81.44M - $81.44M | $0.00 | -$60.80 | 1 |
| Dec 2019 | $30.00M | $30.00M - $30.00M | $0.00 | -$63.40 | 1 |
| Dec 2018 | $20.00M | $20.00M - $20.00M | $0.00 | -$360.00 | 1 |
| Dec 2015 | $2.50M | $2.50M - $2.50M | $0.00 | -$200.00 | 1 |